Literature DB >> 15185880

Reflux laryngitis in a patient with Zollinger Ellison syndrome and the role of epidermal growth factor.

Benjamin M Weinberg1, David S Oh, Gordon V Ohning, Joseph R Pisegna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15185880      PMCID： PMC6736585          DOI： 10.1023/b:ddas.0000026320.17006.14

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  18 in total

1.  Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high.

Authors:  D C Metz; J R Pisegna; V A Fishbeyn; R V Benya; K M Feigenbaum; P D Koviack; R T Jensen
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

2.  Salivary epidermal growth factor in patients with and without acid peptic disease.

Authors:  D M Maccini; B C Veit
Journal:  Am J Gastroenterol       Date:  1990-09       Impact factor: 10.864

3.  Zollinger-Ellison syndrome. Clinical presentation in 261 patients.

Authors:  P K Roy; D J Venzon; H Shojamanesh; A Abou-Saif; P Peghini; J L Doppman; F Gibril; R T Jensen
Journal:  Medicine (Baltimore)       Date:  2000-11       Impact factor: 1.889

4.  Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: its protective potential.

Authors:  J Sarosiek; R T Jensen; P N Maton; D A Peura; D Harlow; T Feng; R W McCallum; J R Pisegna
Journal:  Am J Gastroenterol       Date:  2000-05       Impact factor: 10.864

Review 5.  Reflux laryngitis: pathophysiology, diagnosis, and management.

Authors:  E J Ormseth; R K Wong
Journal:  Am J Gastroenterol       Date:  1999-10       Impact factor: 10.864

6.  Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion.

Authors:  David C Metz; Elaine Soffer; Chris E Forsmark; Byron Cryer; William Chey; Wieslaw Bochenek; Joseph R Pisegna
Journal:  Am J Gastroenterol       Date:  2003-02       Impact factor: 10.864

7.  The interrelationship between salivary epidermal growth factor and the functional integrity of the esophageal mucosal barrier in the rat.

Authors:  J Sarosiek; T Feng; R W McCallum
Journal:  Am J Med Sci       Date:  1991-12       Impact factor: 2.378

8.  Role of salivary epidermal growth factor in the maintenance of physicochemical characteristics of oral and gastric mucosal mucus coat.

Authors:  J Sarosiek; J Bilski; V L Murty; A Slomiany; B L Slomiany
Journal:  Biochem Biophys Res Commun       Date:  1988-05-16       Impact factor: 3.575

9.  Reflux esophagitis in patients with Zollinger-Ellison syndrome.

Authors:  L S Miller; R Vinayek; H Frucht; J D Gardner; R T Jensen; P N Maton
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

Review 10.  The effect of Zollinger-Ellison syndrome and neuropeptide-secreting tumors on the stomach.

Authors:  J R Pisegna
Journal:  Curr Gastroenterol Rep       Date:  1999-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.